Internet for Pharmaceutical and Biotech Communities
| Newsletter | Post Jobs | Advertising |
 
 

 

  

Pharm/Biotech Resources

Outsourcing Guide

Cont. Education

Software/Reports

Training Courses

Web Seminars

Jobs

Buyer's Guide

Home Page

Pharm Patents /
Licensing

Pharm News

Federal Register

Pharm Stocks

FDA Links

FDA Warning Letters

FDA Doc/cGMP

Pharm/Biotech Events

Consultants

Advertiser Info

Newsletter Subscription

Web Links

Suggestions

Site Map
 

 
   


Patent Classification

Treatment, Reproductive Related Disorders

  1. Mutant glycoproteins
     
  2. WNT signalling in reproductive organs
     
  3. Inactivated respiratory syncytial viral vaccines

  4. Screening test for the lethal genetic trait of recurrent spontaneous pregnancy loss
     
  5. Methods for treating male erectile dysfunction

Treatment, Restless Leg Syndrome

  1. Methods and compositions for administration of iron for the treatment of restless leg syndrome
     
  2. Ketamine treatment of restless legs syndrome
     
  3. Use of valeriana for the treatment of restless leg syndrome and related disorders

Treatment, Rheumatoid Arthritis

  1. Diclofenac sodium oral pharmaceutical
     
  2. Method for treating autoimmune and alloimmune diseases
     
  3. Active substance patch, kind to the skin, for transdermal administration of nonsteroidal antirheumatics
     
  4. Sphingomyelin enhancement of tumor therapy
     
  5. Treatment for joint inflammation
     
  6. Systemic use of 5-HT3 receptor antagonists against rheumatic inflammatory processes

  7. Anti-TNF antibodies and methotrexate in the treatment of arthritis and crohn's disease

Treatment, Rhinitis/Sinusitis

  1. Aerosolized anti-infectives, anti-inflammatories, and decongestants for the treatment of sinusitis
     
  2. Nasal passage cleaning composition
     
  3. Composition for cleansing the sinuses
     
  4. Lipooligosaccharide based vaccine for prevention of moraxella (branhamella)catarrhalis infections in humans
     
  5. Aerosolized anti-infectives, anti-inflammatories, and decongestants for the treatment of sinusitis
     
  6. Single-dose antihistamine/decongestant formulations for treating rhinitis

Treatment, Ribozyme Related Therapy

  1. Ribozyme therapy for the treatment of proliferative skin and eye diseases

Treatment, Rubella

  1. Highly infectious rubella virus DNA constructs and methods of production
     
  2. Specificity in the detection of anti-rubella IGM antibodies
     
  3. Specificity in the detection of anti-rubella IgM antibodies

Treatment, Sebaceous Gland Disorders

  1. Method for treating a cholinergic influenced sweat gland
     
  2. Compositions and methods for decreasing sebum production

Treatment, Sepsis/Septic Shock

  1. Methods of identifying individuals at reduced risk of sepsis
     
  2. Induction of antibiotic proteins and peptides by LAIT/sCD14-protein
     
  3. Method for diagnosis of sepsis by determination of S100B
     
  4. Early detection of sepsis
     
  5. Compositions and methods for the diagnosis and treatment of sepsis
     
  6. Methods of treatment for septic shock with urine extract
     
  7. Protein C or activated protein C-like molecules
     
  8. Antagonists of HMG1 for treating inflammatory conditions
     
  9. Antagonists of HMG1 for treating inflammatory conditions
     
  10. Anti-sepsis conjugate vaccine
     
  11. Compositions and methods for the treatment of sepsis
     
  12. Animal models and methods for sepsis
     
  13. Therapeutic agent for the treatment of septicaemia its preparation and use
     
  14. Immunoadsorber for use in sepsis therapy
     
  15. Compositions and methods for the treatment of sepsis
     
  16. Treatment of sepsis with TAFI
     
  17. Interferon-gamma-binding molecules for treating septic shock, cachexia, immune diseases and skin disorders
     
  18. Method for removing pyrogens from plasma and blood for treatment of septic shock
     
  19. Compositions and methods for the treatment of sepsis
     
  20. Method of treating systemic inflammatory response syndrome
     
  21. Immunological activity for a peptide of the limulus anti-LPS factor
     
  22. Synthetic peptides with antimicrobial and endotoxin neutralizing properties for management of the sepsis syndrome
     
  23. Method of treating sepsis and ARDS with chemokine .beta.-4

  24. Interferon-gamma-binding molecules for treating septic shock, cachexia, immune diseases and skin disorders

  25. Enhanced circulation effector composition and method
     
  26. Methods and compositions for ameliorating the symptoms of sepsis
     
  27. Methods for prevention and treatment of septic shock

Treatment, Sexually Transmitted Diseases/Syphilis

  1. .beta.-cyclodextrin compositions, and use to prevent transmission of sexually transmitted diseases
     
  2. Method for detecting syphilis using synthetic antigens
     
  3. Human papilloma virus treatment
     
  4. Compositions and methods for trapping and inactivating pathogenic microbes and spermatozoa
     
  5. Methods of treating human females susceptible to HSV infection
     
  6. Methods for isolating T. pallidum rare outer membrane proteins
     
  7. Immune responses against HPV antigens elicited by compositions comprising an HPV antigen and a stress protein or an expression vector capable of expression of these proteins
     
  8. Vaginal lactobacillus medicant
     
  9. Composition and method for prevention of sexually transmitted diseases, including aids
     
  10. Method for preventing sexually transmitted diseases
     
  11. Topical application of antibodies for prophylaxis against sexually transmitted diseases and pregnancy

Treatment, Shock, Cardiovascular/Physiological

  1. Albumin-based colloid composition and method of use in treating hypovolemia and multiorgan dysfunction
     
  2. Method for regulation of microvascular tone
     
  3. Treatment of shock using adrenomedullin binding protein-1
     
  4. Method for treatment and prevention of physiological shock

Treatment, Sickle Cell Disease

  1. Gene regulation therapy involving ferritin
     
  2. Modified annexin proteins and methods for treating vaso-occlusive sickle-cell disease
     
  3. Method of treating sickle cell disease or thalassemia

Treatment, Silicon Deficiency

  1. Complex containing biologically assimilable orthosilicic acid, which is under solid form, stable and concentrated, and a process for preparation of said complex 

Treatment, Skin/Nail Related Disorders/Cancer

  1. Methods of treating dermal ulcers using glucans
     
  2. Method of production of artificial skin
     
  3. Methods and compositions for enhancing collagen and proteoglycan synthesis in the skin
     
  4. Administration of 6-[3-(1-adamantyl)-4-methoxyphenyl]-2-naphthoic acid for the treatment of dermatological disorders
     
  5. Methods of treating cutaneous ulcers and grafts using IL-23
     
  6. Monoclonal antibodies to human high molecular weight-melanoma associated antigen
     
  7. Method and composition for treating skin wounds with epidermal growth factor
     
  8. Monoclonal antibody 1A7 and use for the treatment of melanoma and small cell carcinoma
     
  9. si-RNA-mediated gene silencing technology to inhibit tyrosinase and reduce pigmentation
     
  10. Identification of a novel BHD gene
     
  11. Melanoma therapy
     
  12. Modulation of insulin like growth factor I receptor expression
     
  13. Methods for treating retinoid responsive disorders using selective inhibitors of CYP26A and CYP26B
     
  14. Treatment and composition for achieving skin anti-aging benefits by corneum protease activation
     
  15. Antibodies to a polypeptide encoded by a nucleic acid overexpressed in melanoma
     
  16. Method of treating granuloma annulare or sarcoid
     
  17. Microparticle-based diagnostic methods
     
  18. Topical composition comprising feverfew
     
  19. Use of placental alkaline phosphatase to promote skin cell proliferation
     
  20. Skin treatment for relief of itch
     
  21. Use of microphthalmia for diagnosis, prognosis and/or treatment of melanoma
     
  22. Topical acne vulgaris medication with a sunscreen
     
  23. Benzoyl peroxide compositions having increased potency
     
  24. Methods of increasing the efficacy of peroxides
     
  25. Nucleic acid underexpressed in melanoma
     
  26. Treatment of holocrine gland dysfunction with clostridia neurotoxins
     
  27. Treatment of melanoma by reduction in clusterin levels
     
  28. Use of nitroxides in treating skin disease
     
  29. Pharmaceutical composition comprising dimethylsulfoxide and ozone
     
  30. Topical composition and method for the treatment and prophylaxis of dermal irritations
     
  31. Method of treating skin wounds with vectors encoding hepatocyte growth factor
     
  32. Artificial dermis and production method therefor
     
  33. Compositions and methods for enhancing corticosteroid delivery
     
  34. Treatment of ungual and subungual diseases
     
  35. Drug therapy for celiac sprue
     
  36. Formulations for the prevention or the treatment of diseases affecting mucosae or skin, or for pregnancy prevention, and an applicator for the delivery of topical formulations into mucosal cavities
     
  37. Use of prenylated flavones
     
  38. Bandage composition containing phage associated lytic enzymes useful for treating dermatological infections
     
  39. Emulsion containing ascorbic acid and its uses in the cosmetics and dermatological fields
     
  40. Methods for treatment of cutaneous T-cell lymphoma
     
  41. Recombinant oncolytic adenovirus for human melanoma
     
  42. Stable water in oil aminophylline emulsions
     
  43. Method of orally treating inflammatory skin conditions with prodrugs of 5-fluorouracil
     
  44. Pharmaceutical compositions and methods for managing skin conditions
     
  45. Melanoma vaccine and methods of making and using same
     
  46. Composition and method for treatment and prevention of pruritis
     
  47. Compositions for the treatment of pigmentation disorders and methods for their manufacture
     
  48. Method for examining the involvement of opioid peptides in prurtis
     
  49. Oral composition and method for the treatment of inflammatory cutaneous disorders
     
  50. Methods for inhibiting cutaneous inflammation and hyperpigmentation
     
  51. Use of a polypeptide for treatment of pruritus in animals
     
  52. Process and composition for enhancing the action of vitamin a on the cellular activity of an individual, and use of vitamin c
     
  53. Stable hydrogen peroxide compositions, products and methods of use
     
  54. Antioxidants in clusters of structured water
     
  55. Skin penetration enhancing components
     
  56. Laminin chains: diagnostic uses
     
  57. Genes and polynucleotides associated with ultraviolet radiation-mediated skin damage and uses thereof
     
  58. MHC-class II restricted melanoma antigens and their use in therapeutic methods
     
  59. Skin and mucosal treatment formulation
     
  60. Epidermal melanocyte culture formulations
     
  61. Topical administration of pharmacologically active bases in the treatment of inflammatory dermatoses
     
  62. Use of a polypeptide for treatment of pruritis in animals
     
  63. Melanoma therapy
     
  64. Stabilized silver-ion amine complex compositions and methods
     
  65. Antibodies against the MUC18 antigen
     
  66. Cultured skin and method of manufacturing the same
     
  67. Topical medicament for treating nappy rash
     
  68. Animal model system for photodamage, photoaging and skin wounding
     
  69. Use of KPV tripeptide for dermatological disorders
     
  70. Method for treating skin disorders
     
  71. Compositions for regenerating tissue that has deteriorated, and methods for using such compositions
     
  72. Dermatomycosis vaccine
     
  73. Compositions and methods for high sorption of skin materials and delivery of sulfur
     
  74. Genetically modified fibroblast cells
     
  75. Gentle-acting skin disinfectants
     
  76. Method of treating pruritis and composition thereof
     
  77. Topical administration of pharmacologically active bases in the treatment of warts
     
  78. Composition and method for treating diaper rashes and skin irritations caused by acidic secretions
     
  79. Hyaluronic Acid in soft gel form
     
  80. Multi-purpose skin balm including skin balm for psoriasis
     
  81. Ribozyme therapy for the treatment of proliferative skin and eye diseases
     
  82. Method of using hydroxycarboxylic acids or related compounds for treating skin changes associated with intrinsic and extrinsic aging
     
  83. Method of prophylaxis or treatment of antigen presenting cell driven skin conditions using inhibitors of the CD2/LFA-3 interaction
     
  84. Compositions and methods for enhancing corticosteroid delivery
     
  85. System and method for evaluating agents which prevent oxidative damage
     
  86. Preparation for the treatment of pigmentation disorders
     
  87. Bandage composition containing a phage associated lytic enzyme
     
  88. Methods of increasing the efficacy of peroxides
     
  89. Keratinocyte cultures and uses thereof
     
  90. Treatment of dermal tumors, warts, and viral infections of the respiratory tract in humans using heat-killed P. acnes
     
  91. DNA repair polypeptides and methods of use
     
  92. Method for detection of biological factors in epidermis
     
  93. Vaccine adjuvants for immunotherapy of melanoma
     
  94. Method of treating palmar and plantar fibromatosis
     
  95. Conjugate for treating inflammatory infectious and/or skin diseases
     
  96. Transgenic mouse model of basal cell carcinoma
     
  97. Anti-irritating rosacea treatment
     
  98. Chinese herbal composition for treating eczema and psoriasis
     
  99. Methods for treatment of inflammatory diseases
     
  100. Curcumin and curcuminoid inhibition of angiogenesis
     
  101. Allergic contact dermatitis treatment and composition therefor
     
  102. Reparatives for chemosurgery and laser (thermal) therapy
     
  103. Epidermis/dermis equivalents and aged skin equivalents shaped therefrom
     
  104. Method for delivering ascorbic acid and acetone to the dermal layer of the skin
     
  105. Topical capsaicin preparation
     
  106. Method for combating summer eczema and malanders
     
  107. Keratinocyte derived protease
     
  108. Use of polypeptides or nucleic acids for the diagnosis or treatment of skin disorders and wound healing and for the identification of pharmacologically active substances
     
  109. Compositions having comfrey and methods for reducing retinoid-induced skin irritation
     
  110. Collagen production promoter composition
     
  111. Methods for treatment of inflammatory diseases
     
  112. Use of nuclease to reduce wrinkles and discolorations in humans
     
  113. Method for inhibition of photocarcinogenesis or photoimmunosuppression using niacin
     
  114. Topical pharmaceutical base with anti-pruritic and/or anti-inflammatory drugs
     
  115. Creams containing vitamin D3 derivatives
     
  116. Methods and compositions for the protection of mitochondria
     
  117. Method for inhibiting skin lesion formation using histamine as the active ingredient
     
  118. Antioxidants in clusters of structured water
     
  119. Use of bacterial phage associated lysing enzymes for treating dermatological infections
     
  120. Bioactive glass treatment of inflammation in skin conditions
     
  121. Method for the topical treatment and prevention of inflammatory disorders and related conditions using extracts of feverfew (Tanacetum parthenium)

  122. Method for diminishing wrinkles and fine lines of the skin by the topical application of .DELTA.5-androstene-3.beta.-ol-7, 17 dione and metabolizable precursors thereof

  123. Chinese herbs extract

  124. Use of plant extracts for treatment of acne and furuncle

  125. Betamethasone- and hyaluronic acid-treated thin adhesive plaster for the treatment of psoriasis dermatitis and dermatosis

  126. Methods of hydrating mammalian skin comprising oral administration of a defined composition

  127. Method of promoting skin cell metabolism

  128. Composition and method for topically treating Peyronie's Disease, Dupuytren's hand contracture, Ledderhose Fibrosis, erectile dysfunction arising from plaque accumulations, and scarring

  129. Physiological combination of active substances to enhance the skin's defenses against noxious agents

  130. Method and composition for the treatment of scars
     
  131. Anti-inflammatory compositions comprising peptide derivatives of .alpha.-MSH/algal extracts
     
  132. Reparatives for ultraviolet radiation skin damage
     
  133. Methods for the treatment of immunologically-mediated skin disorders
     
  134. Composition and method for control and treatment of cutaneous inflammation
     
  135. Protease inhibitors for use in the treatment of psoriasis
     
  136. Compositions and methods for production and use of an injectable naturally secreted extracellular matrix
     
  137. Method and compositions for topical treatment of damaged tissue using reactive oxygen metabolite production or release inhibitors
     
  138. Nutraceutical composition for protection against solar radiation
     
  139. Antimutagenic compositions for treatment and prevention of photodamage to skin
     
  140. Method for treating pre-malignant basal and squamous cell lesions of the epithelium
     
  141. Method of treating skin disorders with high-strength retinoids
     
  142. Treatment of skin damage using polyenylphosphatidylcholine
     
  143. Targeting of sebaceous follicles as a treatment of sebaceous gland disorders

Treatment, Sleep Disorders/Circadian Rhythms

  1. Buccal, polar and non-polar spray containing zolpidem
     
  2. Methods and compositions for nasal administration of modafinil
     
  3. Compositions and methods for the induction and maintenance of quality sleep
     
  4. Methods for identifying compounds that modulate vigilance states
     
  5. Melatonin-based composition for improved sleep
     
  6. Screening assay to identify modulators of the sleep/wake cycle
     
  7. Administration of hypocretin-1 for treatment of narcolepsy
     
  8. Autonomic nerve regulating agent
     
  9. Sleep inducing toothpaste made with natural herbs and a natural hormone
     
  10. Screening and therapeutic methods for promoting wakefulness and sleep
     
  11. Delivery of alprazolam, estazolam, midazolam or triazolam through an inhalation route
     
  12. Method of treating sleeplessness with melatonin on an acute basis
     
  13. Methods and compositions for improving sleep
     
  14. Neuropharmacological treatments of sleep-related breathing disorders
     
  15. Tryptophan source from plants and uses therefor
     
  16. Administering bacteria to improve sleep
     
  17. Mediation of circadian rhythms

  18. Methods and compositions for treating or preventing sleep disturbances and associated illnesses using very low doses of cyclobenzaprine

  19. Use of serotonin agonists to alleviate disordered breathing episodes in a mammal

  20. Method for treating or preventing sleep disorders

  21. Pharmacological treatment for sleep apnea
     
  22. Sleep quality improvement using a growth hormone secretagogue

Treatment, Smallpox

  1. Methods and compositions for the identification of anti-poxvirus agents
     
  2. Smallpox vaccine
     
  3. Oral vaccinia formulation
     
  4. Smallpox vaccine
     
  5. DNA vaccines against poxviruses

Treatment, Smoking Cessation

  1. Methods of reducing the nicotine content of tobacco plants and tobacco plants obtained thereby
     
  2. Method and apparatus for reducing the incidence of tobacco use
     
  3. Beverage treated with nicotine
     
  4. Nicotine replacement applique
     
  5. Treating the effect of nicotine
     
  6. Chewing gum composition for effectively eliminating nicotine accumulated in a human body
     
  7. Therapeutic and diagnostic methods dependent on CYP2A enzymes
     
  8. Two-stage transmucosal medicine delivery system for symptom relief
     
  9. Nicotine-containing, controlled release composition and method
     
  10. Composition and method for smoke detoxification
     
  11. Compositions and methods for the control of smoking
     
  12. Nicotine-containing pharmaceutical compositions giving a rapid transmucosal absorption
     
  13. Method for reducing or eliminating smoking
     
  14. Nicotine mucosal spray
     
  15. Pharmaceutical composition containing two active ingredients for smoking cessation
     
  16. Edible herbal compositions for relieving nicotine craving
     
  17. Inhibition of psychostimulant-induced and nicotine-induced craving
     
  18. Herbal composition as a substitute for tobacco
     
  19. Tobacco cembranoids block the expression of the behavioral sensitization to nicotine and inhibit neuronal acetylcholine receptors
     
  20. Nicotine delivery compositions
     
  21. Methods and compositions for treating chronic disorders using optically pure (+)-bupropion
     
  22. Plantago majorand piper methysticum compound for use in treating a tobacco or nicotine habit
     
  23. Compositions and methods for the control of smoking
     
  24. Nicotine lozenge
     
  25. Nicotine beverage
     
  26. Intestinal absorption of nicotine to treat nicotine responsive conditions
     
  27. Methods to abate the use of tobacco by humans
     
  28. Solution containing nicotine

Treatment, Snake/Insect Bite

  1. Antivenom immunesera

Treatment, Snoring

  1. Therapeutic agent for the suppression of snoring noises

Treatment, Spinal Cord/Brain Injury

  1. Treatment of brain damage
     
  2. Treatment of and/or prophylaxis against brain and spinal cord injury
     
  3. Mechanically elongated neuronal cells

Treatment, Spinal Muscular Atrophy

  1. Treatments for spinal muscular atrophy

Treatment, Streptococcus/Staphylcoccus Related Diseases

  1. Nucleic acid and amino acid sequences relating to Streptococcus pneumoniae for diagnostics and therapeutics
     
  2. Nucleic acid and amino acid sequences relating to Staphylococcus epidermidis for diagnostics and therapeutics
     
  3. Methods and compositions for the treatment and prevention of staphylococcal infections
     
  4. Staphylococcus antibodies
     
  5. Streptococcus uberis adhesion molecule
     
  6. Protein-based Streptococcus pneumoniae vaccines
     
  7. Nucleic acids coding for adhesion factor of group B streptococcus, adhesion factors of group B streptococcus and further uses thereof
     
  8. Vaccine against streptococci
     
  9. Nucleic acid and amino acid sequences relating to Staphylococcus epidermidis for diagnostics and therapeutics
     
  10. Peptide vaccines against group A streptococci
     
  11. Vaccine against staphylococcus intoxication
     
  12. Compositions and methods for affecting virulence determinants in bacteria
     
  13. Methods and compositions for the treatment and prevention of Staphylococcus and other bacterial infections
     
  14. Multivalent streptococcal vaccine compositions and methods for use
     
  15. Immunization of dairy cattle with chimeric GapC protein against Streptococcus infection
     
  16. Streptococcal C5a peptidase vaccine
     
  17. Collagen-binding proteins from Streptococcus pyogenes
     
  18. Nucleic acid and amino acid sequences relating to Streptococcus pneumoniae for diagnostics and therapeutics
     
  19. Nucleic acid and amino acid sequences relating to Streptococcus pneumoniae for diagnostics and therapeutics
     
  20. Streptococcus pneumoniae proteins and vaccines
     
  21. Nucleic acid and amino acid sequences relating to streptococcus pneumoniae for diagnostics and therapeutics
     
  22. Compositions and methods for treatment of staphylococcal infection while suppressing formation of antibiotic-resistant strains
     
  23. Nucleic acid and amino acid sequences relating to Streptococcus pneumoniae for diagnostics and therapeutics
     
  24. Compositions and methods involving an essential Staphylococcus aureus gene and its encoded protein
     
  25. Kits for use in detecting resistance to streptogramin A and related compounds
     
  26. Nasal spray for treating streptococcal infections
     
  27. Use of hop acids to inhibit growth of Staphylococcus aureus and prevent toxic shock syndrome
     
  28. Virulence genes, proteins, and their use
     
  29. Multiple antigenic peptides immunogenic against Streptococcus pneumonia
     
  30. Streptococcus pneumoniae proteins and vaccines
     
  31. Treatment of E. faecium infection
     
  32. Ophthalmic ointments for treating infective eye disease
     
  33. Pneumococcal protein homologs and fragments for vaccines
     
  34. Process and materials for the rapid detection of streptococcus pneumoniae employing purified antigen-specific antibodies
     
  35. Collagen-binding proteins from streptococcus pyogenes
     
  36. Group A streptococcal vaccines
     
  37. Bacterial superantigen vaccines
     
  38. Staphylococcal immunotherapeutics via donor selection and donor stimulation
     
  39. Chewing gum containing phage associated lytic enzymes for treating streptococcal A infections
     
  40. Rnase P polypeptides, polynucleotides, and methods using their mechanisms of action
     
  41. Lymphocyte-derived antimicrobial protein (LDAP) and methods of isolating and producing and using the protein
     
  42. Vaccine compositions comprising Streptococcus pneumoniae polypeptides having selected structural MOTIFS
     
  43. Compositions and methods for treatment of staphylococcal infection while suppressing formation of antibiotic-resistant strains
     
  44. IgG-binding protein from Staphylococcus and nucleotide sequence encoding this protein
     
  45. Polynucleotides and their use for detecting resistance to streptogramin A or to streptogramin B and related compounds
     
  46. Streptococcus iniae vaccine

Treatment, Stroke

  1. Method for the treatment of cerebral ischaemia and use of erythropoietin or erythropoietin derivatives for the treatment of cerebral ischaemia
     
  2. Composition and method for preventing recurrence of stroke
     
  3. HDL for the treatment of stroke and other ischemic conditions
     
  4. Mutation associated with strokes
     
  5. Prevention of brain damage in stroke
     
  6. Diagnostic assay for stroke
     
  7. Method of improving ischemic muscle function by administering placental growth factor
     
  8. Method for predicting cardiovascular events
     
  9. Genes involved in stroke response and/or regulated by FK506, proteins encoded thereby, and methods of use
     
  10. Composition and treatment method for brain and spinal cord injuries
     
  11. Method of diagnosing ischemic stroke via UCP-2 detection
     
  12. Polydithicarbamate-containing non-targeting marcomolecules and the use thereof for therapeutic and diagnostic applications
     
  13. Method of treating cytotoxic damage
     
  14. Treatment of cerebral disorders by inhibition of IL-8 binding to receptor
     
  15. Metabolic intervention with GLP-1 or its biologically active analogues to improve the function of the ischemic and reperfused brain
     
  16. Methods for treating vascular disorders
     
  17. Method for aiding cerebral recovery following neurodegeneration
     
  18. Method for improving disturbances of activities of daily living after stroke

Treatment, Sudden Infant Death Syndrome

  1. Use of ammonium compounds and/or urea

Treatment, Surgery, Bypass/Heart

  1. Use of xenon for the control of neurological deficits associated with cardiopulmonary bypass
     
  2. Organ arrest, protection and preservation
     
  3. Postsurgical treatment with dichloroacetate
     
  4. Pharmacologic drug combination in vagal-induced asystole

Treatment, Surgery, General

  1. Protein crosslinkers, crosslinking methods and applications thereof
     
  2. Biomaterials for preventing post-surgical adhesions comprised of hyaluronic acid derivatives
     
  3. Dressing for treatment of short wounds located in high tension areas
     
  4. Carrier with solid fibrinogen and solid thrombin
     
  5. Dilution resistant viscoelastic compositions
     
  6. Fibrinogen plus a non-plasmin-acting fibrinolysis inhibitor for the reduction or prevention of adhesion formation
     
  7. Tissue glue with improved antiadhesive properties
     
  8. Methods for treating post-surgical pain by administering an anti-nerve growth factor antagonist
     
  9. Method of inhibition of pain and inflammation during surgery comprising administration of soluble TNF receptors
     
  10. Methods for forming regional tissue adherent barriers and drug delivery systems
     
  11. Suturable adhesion-preventing membrane
     
  12. Salt solution for colon cleansing
     
  13. Method for preparing a calcium phosphate pasty material for injection
     
  14. Light energized tissue adhesive
     
  15. Modifying tissue surfaces by liquid crystal formation
     
  16. Light energized tissue adhesive conformal patch

Treatment, Symptomatic Treatment

  1. Methods for treating disease states comprising administration of low levels of antibodies

Treatment, Systemic Lupus Erythematosus

  1. Method for treatment of SLE

 

     
[ Outsourcing Guide ] [ Cont. Education ] [ Software/Reports ] [ Training Courses ]
[ Web Seminars ] [ Jobs ] [ Consultants ] [ Buyer's Guide ] [ Advertiser Info ]

[ Home ] [ Pharm Patents / Licensing ] [ Pharm News ] [ Federal Register ]
[ Pharm Stocks ] [ FDA Links ] [ FDA Warning Letters ] [ FDA Doc/cGMP ]
[ Pharm/Biotech Events ] [ Newsletter Subscription ] [ Web Links ] [ Suggestions ]
[ Site Map ]